Mobile Cardiac Telemetry Devices Market: Current Scenario and Forecast (2019-2025): Emphasis on Technology (Lead-Based, Patch Based), End-Users (Hospitals, Ambulatory Surgical Centres, Home Setting) and Region/Country

Region:Global

Author(s):

Product Code:UMHE19189

Download Sample Report download
Buy the Full ReportStarting from $3500
Published on

November 2019

Total pages

231

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $3500

About the Report

About the Report

Mobile cardiac telemetry devices derived revenue of USD 563.7 million in 2018 and are expected to fetch USD 1,264 million by 2025 displaying tremendous CAGR of 12.34% over the forecast period (2019-2025). The global Mobile Cardiac Telemetry Devices market is segmented based on technology (lead-based and patch-based devices) and end-user (hospitals, ambulatory surgical centers and home settings). Under the technology segment, in 2018, the lead-based devices dominated the global mobile cardiac telemetry devices market with the maximum share in terms of revenue. Based on estimation, the segment occupied 60.2% share. However, the patch-based devices are anticipated to grow by the highest CAGR of 13.25%. In recent years the prevalence of chronic diseases has increased due to the rise in life expectancy and changes in lifestyle, and thus people suffering from these pathologies often need continuous monitoring of their vital signs. The mobile health field can provide new access opportunities for treatment and medical services, constituting a valuable support instrument for both patients and doctors. Mobile cardiac telemetry (MCT) is a relatively new technology, first approved in 2002 by the US Food and Drug Administration (FDA), which provides continuous real-time outpatient electrocardiographic monitoring for extended periods of time. MCT allows detection of both symptomatic and asymptomatic arrhythmias and has been proven to provide superior diagnostic capability for patients with palpitations, syncope, and pre-syncope. It also allows accurate monitoring of a patient's rhythm during outpatient drug titration, as well as detection of both symptomatic and asymptomatic atrial fibrillation after cardiac ablation. The lead based MCT devices market at global scale was evaluated at USD 339.2 million in 2018 and is projected to witness astonishing CAGR of 11.71% during the forecast period. In addition, patch-based devices held 39.8% market share in the respective market generating revenue of USD 224.5 million in 2018.

Mobile Cardiac Telemetry (MCT) is becoming common as the device is far less labor-intensive for the patient as compared to the traditional Event Monitor. Cardiac Event Monitor is a device used for detecting ONLY symptoms felt by the patient. The MCT monitor has the capability of transmitting both symptoms felt by the patient as well as abnormalities that are not felt by the patient. Furthermore, MCT monitoring is useful as the communication is constant if there are messages needed to be transmitted to the patient, the process is simple and reliable because it uses standard cell phone technology. Mobile Cardiac Telemetry monitoring is the wave of the future, owing to its multiple advantages compared to other long-term monitoring options. MCT monitoring technology can be considered a superior method for detecting ECG abnormalities as it captures cardiac abnormalities in real-time. The expedited nature of MCT can potentially improve diagnostic care and lower healthcare costs over the long run. The automatic monitoring outside the hospital provides clear clinical benefits for the patients, physicians and healthcare providers. Potential medically relevant problems can be recognized and addressed proactively, avoiding unnecessary hospitalization costs.

Secondly, the robust incorporation of (cardiac) telemonitoring into a given clinic's work routine will likely require a commitment to redirect certain internal resources and work processes in order to reap the full benefits of a telemetric patient monitoring. Unlike many medical innovations, the true benefits of cardiac telemonitoring will be spread among those involved in the patient care cycle. Finally, a growing number of hospitals and pacemaker clinics have already recognized the inherent value of adopting this new technology to improve work efficiency, deliver more timely urgent medical responses when cardiac events occur. They also use this technology for establishing a productive professional interface with a given patient's non-specialist physicians and caregivers.

Hospitals are the major end-users of mobile telemetry device technology; the segment generated a revenue of USD 350.5 million in 2018. The hospital's end-user segment is expected to grow at a CAGR of 11.67% during the forecast period to reach a market size of USD 753.8 million by 2025. However, home setting is expected to witness highest CAGR of 14.92% during the forecast period (2019-2025).

Also, for better understanding of the overall adoption rate of mobile cardiac telemetry devices in different developed and developing markets, detailed analysis has been conducted for different regions/countries including North America (US, Canada), Europe (UK, Germany, France, Spain, Italy), Asia-Pacific (China, India, Japan, Australia), and the Rest of the World (Middle East and Latin America). Based on the estimation, Europe dominated the Mobile Cardiac Telemetry devices market, accounting for a revenue share of 31.9% in 2018. The rising incidence of cardiovascular diseases in Europe is influencing the healthcare service providers to implement advanced telehealth services. Hence, the increasing usage of telecardiology is expected to drive the market.

Key Facts on Cardiovascular diseases (CVDs), Global

CVDs are the number 1 cause of death globally: more people die annually from CVDs than from any other cause.

An estimated 17.9 million people died from CVDs in 2016, representing 31% of all global deaths. Of these deaths, 85% are due to heart attack and stroke.

Over three-quarters of CVD deaths take place in low- and middle-income countries.

Out of the 17 million premature deaths (under the age of 70) due to noncommunicable diseases in 2015, 82% are in low- and middle-income countries, and 37% are caused by CVDs.

Most cardiovascular diseases can be prevented by addressing behavioral risk factors such as tobacco use, unhealthy diet and obesity, physical inactivity and harmful use of alcohol using population-wide strategies.

People with cardiovascular disease or who are at high cardiovascular risk (due to the presence of one or more risk factors such as hypertension, diabetes, hyperlipidemia or already established disease) need early detection and management using counseling and medicines, as appropriate

Numerous companies have marked their presence in the mobile cardiac telemetry devices market with a continued focus on product expansions, investments, business expansion, product launches and collaborations. They continue to offer wide range of smart devices that cater to farm needs and further result in enhanced crop productivity and optimum utilization of resources. With an objective to stimulate the overall adoption of mobile cardiac telemetry devices across the developing and developed nations specifically in the Asia Pacific, Europe region, these players have adopted various strategies to enhance the penetration of modern mobile cardiac telemetry devices. Some of the major players operating in the global mobile cardiac telemetry devices market include Asahi Kasei Corp., BioTelemetry Inc., Biotricity, Comarch, Hill-Rom Holdings Inc, Infobionic, Koninklijke Philips N.V., Medicalgorithmics, Medicomp and Preventice among others.

Global Mobile Cardiac Telemetry Devices market generated revenue of USD 563.7 million in 2018. The devices market is expected to grow at a CAGR of 12.34% during the forecast period to reach a market valuation of USD 1,264 million by 2025. Europe dominated the global mobile cardiac telemetry devices market, accounting for a revenue share of 31.9% in 2018.

Products


Companies

Asahi Kasei Corporation, BioTelemetry Inc, Biotricity, Comarch, Hill-Rom Holdings Inc, Infobionic, Koninklijke Philips N.V., Medicalgorithmics, Medicomp, Preventice Solutions

Table of Contents

Table of Contents

1. MARKET INTRODUCTION

1.1 Market Definition 17

1.2 Objective of the Study 17

1.3 Limitation 17

1.4 Stakeholders 18

1.5 Currency used in the Report 18

1.6 Scope of the Global Mobile Cardiac Telemetry Devices Market Study 18

2. RESEARCH METHODOLOGY OR ASSUMPTION 19

2.1 Research Methodology for Global Mobile Cardiac Telemetry Devices Market Study 19

2.1.1 Main objective of the Global Mobile Cardiac Telemetry Devices Market Study 20

3. INDUSTRY PERFORMANCE 21

4. EXECUTIVE SUMMARY 22

4.1 Key Facts on Cardiovascular diseases (CVDs), Global 23

5. MARKET OVERVIEW 25

5.1 Market Introduction 25

5.2 Market Trend & Drivers 29

5.2.1 Increasing prevalence of Cardiovascular Diseases 29

5.2.1.1 Market trends reshaping the CVD market 31

5.2.1.1.1 Increasing demand for value 31

5.2.1.1.2 The rising uptake of Innovative Treatment Technologies 32

5.2.1.1.3 Growing Digital Solutions Adoption 33

5.2.1.1.4 Changing MedTech competitive landscape 33

5.2.1.1.5 Evolving provider and care delivery shifts 34

5.2.2 Rising Geriatric Population 34

5.2.3 Next-Generation Devices for Miniaturization, Faster Processing and Connectivity 36

5.2.4 Increasing Medical Tourism in Emerging Nations 36

5.3 Market Challenges 38

5.3.1 Clinical Effectiveness 38

5.3.2 Need for validation, cost-effectiveness 40

5.3.3 Data Security 41

5.4 Market Trends 43

5.4.1 Interoperability and Wireless Technology to Enhance Real-Time, Remote Monitoring 43

5.4.2 Transition of Care Delivery from Hospital to Home 45

6. REIMBURSEMENT POLICY 46

6.1 General Overview 46

6.1.1 Holter Monitoring reimbursement 46

6.1.2 Mobile Cardiac Telemetry Reimbursement 46

6.1.3 Cardiac Event Monitoring Reimbursement 47

6.2 Medicare National Coverage 47

6.3 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/ telemetry 47

6.3.1 Reimbursement 53

6.3.2 Reimbursement in Europe 55

7. LEGAL & REGULATORY FRAMEWORK 59

7.1 General Overview 59

7.2 Criteria/Guidelines 60

7.3 Criteria/Guidelines 60

7.4 Limitations 61

7.5 Administrative Guidelines 61

7.6 Observational Study 63

7.7 Practice Guidelines and Position Statements 63

7.8 Telemetry Devices to Monitor Cardiac Patients: Safety and Guidelines in Canada 64

7.9 The legal framework in regulating remote (cardiac) monitoring in France 64

7.10 The legal framework in regulating remote (cardiac) monitoring in Italy 64

8. DEMAND AND SUPPLY SIDE ANALYSIS 66

8.1 Demand Side Analysis 66

8.2 Supply Side Analysis 68

8.2.1 Top Product Launches under Mobile Cardiac Telemetry Devices 70

8.2.2 Top Partnerships under Mobile Cardiac Telemetry Devices 72

8.2.3 Top Mergers & Acquisitions under Mobile Cardiac Telemetry Devices 73

8.2.4 Top Business Expansion & Investment under Mobile Cardiac Telemetry Devices 75

9. VALUE CHAIN ANALYSIS 77

9.1 Value Chain Analysis 77

10. MARKET INSIGHTS BY TECHNOLOGY 78

10.1 General Overview 78

10.1.1 Lead-Based MCT Device 80

10.1.1.1 Case Study 1- Superiority of MCT Devices 83

10.1.2 Patch Based MCT Device 83

10.1.2.1 Case study 2- Superiority of MCT Devices 85

11. MOBILE CARDIAC TELEMETRY DEVICE MARKET INSIGHTS, BY END-USERS 86

11.1 General Overview 86

11.1.1 Hospitals 90

11.1.1.1 Case Study 3- Superiority of MCT Devices 92

11.1.2 Ambulatory Surgical Centres 92

11.1.2.1 Case study 4- Superiority of MCT Devices 94

11.1.3 Home Setting 94

11.1.3.1 Case Study 5-Cost-Effectiveness of Mobile Cardiac Telemetry 97

12. MARKET INSIGHTS BY REGION 98

12.1 General Overview 98

12.2 North America Mobile Cardiac Telemetry Devices Market (2019-2025) 99

12.2.1 North America MCT Devices Market by Technology 100

12.2.2 North America Mobile Cardiac Telemetry Devices Market by End-User 101

12.2.3 North America Mobile Cardiac Telemetry Devices Market by Country 101

12.2.3.1 United States Mobile Cardiac Telemetry Devices Market (2019-2025) 102

12.2.3.1.1 Facts on Heart Disease in the US 104

12.2.3.1.2 Facts on Coronary Heart Disease (CHD) in the US 104

12.2.3.1.3 Facts on Stoke in the US 105

12.2.3.1.4 US Mobile Cardiac Telemetry Devices Market by Technology 106

12.2.3.1.5 US Mobile Cardiac Telemetry Devices Market by End-User 106

12.2.3.2 Canada Mobile Cardiac Telemetry Devices Market (2018-2025) 107

12.2.3.2.1 Facts on heart disease in Canada 110

12.2.3.2.2 Canada Mobile Cardiac Telemetry Devices Market by Technology 110

12.2.3.2.3 Canada Mobile Cardiac Telemetry Devices Market by End-User 111

12.2.3.3 Rest of North America Mobile Cardiac Telemetry Devices Market (2018-2025) 111

12.2.3.3.1 Rest of NA Mobile Cardiac Telemetry Devices Market by Technology 112

12.2.3.3.2 Rest of NA Mobile Cardiac Telemetry Devices Market by End-User 112

12.3 Europe Mobile Cardiac Telemetry Devices Market (2018-2025) 113

12.3.1 Facts on Cardiovascular Disease in Europe 114

12.3.2 Europe Mobile Cardiac Telemetry Devices Market by Technology 115

12.3.3 Europe Mobile Cardiac Telemetry Devices Market by End-User 115

12.3.4 Europe Mobile Cardiac Telemetry Devices Market by Country 116

12.3.4.1 France Mobile Cardiac Telemetry Devices Market (2019-2025) 116

12.3.4.1.1 France Mobile Cardiac Telemetry Devices Market by Technology 117

12.3.4.1.2 France Mobile Cardiac Telemetry Devices Market by End-User 118

12.3.4.2 Germany Mobile Cardiac Telemetry Devices Market (2018-2025) 118

12.3.4.2.1 Germany Mobile Cardiac Telemetry Devices Market by Technology 121

12.3.4.2.2 Germany Mobile Cardiac Telemetry Devices Market by End-User 121

12.3.4.3 Sweden Mobile Cardiac Telemetry Devices Market (2018-2025) 122

12.3.4.3.1 Sweden Mobile Cardiac Telemetry Devices Market by Technology 124

12.3.4.3.2 Sweden Mobile Cardiac Telemetry Devices Market by End-User 125

12.3.4.4 Netherlands Mobile Cardiac Telemetry Devices Market (2018-2025) 125

12.3.4.4.1 Netherlands Mobile Cardiac Telemetry Devices Market by Technology 127

12.3.4.4.2 Case Study-Cost effectiveness of home telemonitoring (HTM) and nurse telephone support (NTS) 127

12.3.4.4.3 Netherlands Mobile Cardiac Telemetry Devices Market by End-User 128

12.3.4.5 Italy Mobile Cardiac Telemetry Devices Market (2018-2025) 128

12.3.4.5.1 Italy Mobile Cardiac Telemetry Devices Market by Technology 133

12.3.4.5.2 Italy Mobile Cardiac Telemetry Devices Market by End-User 133

12.3.4.6 United Kingdom Mobile Cardiac Telemetry Devices Market (2018-2025) 134

12.3.4.6.1 United Kingdom Mobile Cardiac Telemetry Devices Market by Technology 135

12.3.4.6.2 United Kingdom Mobile Cardiac Telemetry Devices Market by End-User 135

12.3.4.7 Rest of Europe Mobile Cardiac Telemetry Devices Market (2018-2025) 136

12.3.4.7.1 Rest of Europe Mobile Cardiac Telemetry Devices Market by Technology 136

12.3.4.7.2 Rest of Europe Mobile Cardiac Telemetry Devices Market by End-User 137

12.4 Asia Pacific Mobile Cardiac Telemetry Devices Market (2018-2025) 137

12.4.1 Asia Pacific Mobile Cardiac Telemetry Devices Market by Technology 138

12.4.2 Asia Pacific Mobile Cardiac Telemetry Devices Market by End-User 139

12.4.3 Asia Pacific Mobile Cardiac Telemetry Devices Market by Country 139

12.4.3.1 Japan Mobile Cardiac Telemetry Devices Market (2018-2025) 140

12.4.3.1.1 Japan Mobile Cardiac Telemetry Devices Market by Technology 141

12.4.3.1.2 Japan Mobile Cardiac Telemetry Devices Market by End-User 142

12.4.3.2 China Mobile Cardiac Telemetry Devices Market (2018-2025) 142

12.4.3.2.1 China Mobile Cardiac Telemetry Devices Market by Technology 144

12.4.3.2.2 China Mobile Cardiac Telemetry Devices Market by End-User 144

12.4.3.3 India Mobile Cardiac Telemetry Devices Market (2018-2025) 145

12.4.3.3.1 India Mobile Cardiac Telemetry Devices Market by Technology 146

12.4.3.3.2 India Mobile Cardiac Telemetry Devices Market by End-User 147

12.4.3.4 Rest of Asia Pacific Mobile Cardiac Telemetry Devices Market (2018-2025) 147

12.4.3.4.1 Rest of APAC Mobile Cardiac Telemetry Devices Market by Technology 148

12.4.3.4.2 Rest of APAC Mobile Cardiac Telemetry Devices Market by End-User 148

12.5 Rest of World Mobile Cardiac Telemetry Devices Market (2018-2025) 149

12.5.1 Rest of World Mobile Cardiac Telemetry Devices Market by Technology 150

12.5.2 Rest of World Mobile Cardiac Telemetry Devices Market by End-User 150

12.5.3 Rest of World Mobile Cardiac Telemetry Devices Market by Country 151

12.5.3.1 South Africa Mobile Cardiac Telemetry Devices Market (2018-2025) 151

12.5.3.1.1 South Africa Mobile Cardiac Telemetry Devices Market by Technology 153

12.5.3.1.2 South Africa Mobile Cardiac Telemetry Devices Market by End-User 153

12.5.3.2 Brazil Mobile Cardiac Telemetry Devices Market (2018-2025) 154

12.5.3.2.1 Brazil Mobile Cardiac Telemetry Devices Market by Technology 155

12.5.3.2.2 Brazil Mobile Cardiac Telemetry Devices Market by End-User 156

12.5.3.3 Other Countries Mobile Cardiac Telemetry Devices Market (2018-2025) 156

12.5.3.3.1 Other RoW Mobile Cardiac Telemetry Devices Market by Technology 156

12.5.3.3.2 Other RoW Mobile Cardiac Telemetry Devices Market by End User 157

13. COMPETITIVE SCENARIO 158

13.1 Porter s Five forces analysis 158

13.1.1 Bargaining power of the Supplier 158

13.1.2 Bargaining power of Buyer 159

13.1.3 Industry Rivalry 159

13.1.4 Availability of Substitute 159

13.1.5 Threat of New Entrants 159

13.2 Market Share Analysis, by Company 2018 160

13.2.1 Some Major agreements of BioTelemetry 160

13.2.2 Market Share of Key Players in Mobile Cardiac Telemetry Devices, 2018 161

14. TOP COMPANY PROFILES 163

14.1 Asahi Kasei Corporation 163

14.1.1 Key Facts 163

14.1.2 Business Description 163

14.1.3 Key Product/Services Offerings 164

14.1.4 Growth Strategy 165

14.1.5 SWOT Analysis 167

14.1.6 Key Financials 168

14.1.6.1 Revenue Split 169

14.1.7 Recent Developments 169

14.1.7.1 Product Launches 169

14.1.7.2 Partnerships 170

14.1.7.3 Mergers and Acquisitions 170

14.2 BioTelemetry Inc. 171

14.2.1 Key Facts 171

14.2.2 Business Description 171

14.2.3 Key Product/Services Offerings 172

14.2.4 Growth Strategy 172

14.2.5 SWOT Analysis 173

14.2.6 Key Financials 174

14.2.6.1 Revenue Split 175

14.2.7 Recent Developments 175

14.2.7.1 Partnerships (Strategic Alliance) 175

14.2.7.2 Mergers and Acquisitions 175

14.3 Biotricity 177

14.3.1 Key Facts 177

14.3.2 Business Description 177

14.3.3 Key Product/Services Offerings 178

14.3.4 Growth Strategy 180

14.3.5 SWOT Analysis 181

14.3.6 Key Financials 181

14.3.7 Recent Developments 182

14.3.7.1 Biotricity Product Launch 182

14.3.7.2 Biotricity Business Expansion and Investment 183

14.4 Comarch 184

14.4.1 Key Facts 184

14.4.2 Business Description 184

14.4.3 Key Product/Services Offerings 185

14.4.4 Growth Strategy 186

14.4.5 SWOT Analysis 187

14.4.6 Key Financials 188

14.4.6.1 Revenue Split 189

14.4.7 Recent Developments 189

14.4.7.1 Partnership 189

14.4.7.2 Business Expansion & Investments 190

14.5 Hill-Rom Holdings Inc 191

14.5.1 Key Facts 191

14.5.2 Business Description 191

14.5.3 Key Product/Services Offerings 192

14.5.4 Growth Strategy 193

14.5.5 SWOT Analysis 195

14.5.6 Key Financials 196

14.5.6.1 Revenue Split 197

14.5.7 Recent Developments 197

14.5.7.1 Product Launches 197

14.5.7.2 Partnership 198

14.5.7.3 Expansions and Investments 198

14.5.7.4 Mergers and Acquisitions 198

14.5.7.5 Product Launches 199

14.6 Infobionic 200

14.6.1 Key Facts 200

14.6.2 Business Description 200

14.6.3 Key Product/Services Offerings 200

14.6.4 Growth Strategy 201

14.6.5 SWOT Analysis 202

14.6.6 Recent Developments 203

14.6.6.1 Product Launch 203

14.6.6.2 Business Expansion and Investment 203

14.7 Koninklijke Philips N.V. 204

14.7.1 Key Facts 204

14.7.2 Business Description 204

14.7.3 Key Product/Services Offerings 205

14.7.4 SWOT Analysis 207

14.7.5 Key Financials 208

14.7.5.1 Revenue Split, by Region and Segment 209

14.7.6 Recent Developments 209

14.7.6.1 Product Launches 209

14.7.6.2 Partnership 210

14.7.6.3 Merger and Acquisition 210

14.8 Medicalgorithmics 211

14.8.1 Key Facts 211

14.8.2 Business Description 211

14.8.3 Key Product/Services Offerings 212

14.8.4 SWOT Analysis 214

14.8.5 Key Financials 215

14.8.5.1 Revenue Split 216

14.8.6 Recent Developments 216

14.8.6.1 Product Launch 216

14.8.6.2 Partnerships 217

14.8.6.3 Business Expansions and Investments 217

14.8.6.4 Merger & Acquisitions 217

14.9 Medicomp 218

14.9.1 Key Facts 218

14.9.2 Business Description 218

14.9.3 Key Product/Services Offerings 218

14.9.4 SWOT Analysis 220

14.9.5 Recent Developments 220

14.9.5.1 Product Launches 220

14.10 Preventice Solutions 221

14.10.1.1 Key Facts 221

14.10.2 Business Description 221

14.10.3 Key Product/Services Offerings 222

14.10.4 SWOT Analysis 224

14.10.5 Recent Developments 225

14.10.5.1 Product Launches 225


List of Figure

FIG. 1 Scope of the Global Mobile Cardiac Telemetry Devices Market Study 19

FIG. 2 Research Methodology for Global Mobile Cardiac Telemetry Devices Market Study 20

FIG. 3 Global Mobile Cardiac Telemetry Devices Market Size, 2018-2025 (USD Million) 25

FIG. 4 A WBAN architecture for ECG monitoring 28

FIG. 5 Cardiovascular diseases (CVDs) at a Glance, 2017 30

FIG. 6 Total number of deaths due to cardiovascular diseases in the world 2017: 17.3m 31

FIG. 7 Direct Cost of CVD is expected to double from 2011 to 2025 31

FIG. 8 Five market trends impacting the cardiovascular landscape 32

FIG. 9 Value-based Care Payment Models 33

FIG. 10 Global population by broad age group, in 2017, 2030 and 2050 36

FIG. 11 Average Range of Savings in Medical Tourism Using US cost as a benchmark 38

FIG. 12 Potential Consequences of Telemetry Monitoring 40

FIG. 13 Adverse Hospital Outcomes 41

FIG. 14 Potential Benefits of Vital Signs Surveillance 42

FIG. 15 Typical Cloud Computing Structure for Healthcare Systems 44

FIG. 16 Telemonitoring System via Cellular Access 45

FIG. 17 Types of AECG monitors currently available in clinical practice-First-generation external ambulatory ECG monitoring 50

FIG. 18 Second generation external ambulatory ECG monitoring available in clinical practice 51

FIG. 19 Major Risk Factors and Comorbidity for CVD 67

FIG. 20 Major CVD Coexisting Medical Conditions* 2016 68

FIG. 21 Supply Chain of Medical monitoring devices 70

FIG. 22 Value Chain of Medical monitoring devices 78

FIG. 23 Pictorial representation of Lead-based, and Patch-based Mobile Cardia Telemetry Device 79

FIG. 24 Global Mobile Cardiac Telemetry Devices Market Share, by Technology, 2018 & 2025 (%) 80

FIG. 25 Global Mobile Cardiac Telemetry Devices Market Size, by Technology, 2018-25 (USD Mn) 80

FIG. 26 Telemetry functions with 5 lead placements 82

FIG. 27 Global Lead-Based Mobile Cardiac Telemetry Devices Market Size, by Region, 2018-25 (USD Mn) 83

FIG. 28 Process of Patch based Mobile Cardiac Telemetry 85

FIG. 29 Global Patch Based Mobile Cardiac Telemetry Devices Market Size, by Region, 2018-25 (USD Mn) 86

FIG. 30 Dollar Market Share of Cardiac Monitoring Modalities 2018 (%) 89

FIG. 31 Global Mobile Cardiac Telemetry Devices Market Share, by End-User, 2018 & 2025 (%) 90

FIG. 32 Global Mobile Cardiac Telemetry Devices Market Size, by End-Users, 2018-25 (USD Mn) 90

FIG. 33 Mobile Cardiac Telemetry System in hospitals 91

FIG. 34 Global Hospital Mobile Cardiac Telemetry Devices Market Size, by Region, 2018-25 (USD Mn) 93

FIG. 35 Global Ambulatory Surgical Centres Mobile Cardiac Telemetry Devices Market Size, by Region, 2018-25 (USD Mn) 94

FIG. 36 Mobile Cardiac Telemetry System signal transmission in-home setting 95

FIG. 37 The process of use of mobile cardiac telemetry device in home settings 96

FIG. 38 Reasons for Mobile Cardiac Telemetry System implementation in-home setting 96

FIG. 39 Global Home Settings Mobile Cardiac Telemetry Devices Market Size, by Region, 2018-25 (USD Mn) 97

FIG. 40 Global Mobile Cardiac Telemetry Devices Market by Region, 2019 & 2025 (%) 99

FIG. 41 Global Mobile Cardiac Telemetry Devices Market by Region, 2019-25 (USD Million) 99

FIG. 42 North America MCT Devices Market by Technology, 2018-2025 (USD million) 101

FIG. 43 North America Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 102

FIG. 44 North America Mobile Cardiac Telemetry Devices Market by Country, 2018- 2025 (USD Million) 102

FIG. 45 US Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 107

FIG. 46 US Mobile Cardiac Telemetry Devices Market by End-User, 2018- 2025 (USD Million) 107

FIG. 47 Diagnostic Yield of External Loop Monitor VS. Wireless Tele ECG 109

FIG. 48 Cardiophone Real Time 24/7 Monitoring 110

FIG. 49 Canada Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 111

FIG. 50 Canada Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 112

FIG. 51 Rest of North America Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 113

FIG. 52 Rest of North America Mobile Cardiac Telemetry Devices Market by End-User, 2018- 2025 (USD Million) 113

FIG. 53 The annual cost of CVD in the USD in billion 115

FIG. 54 Europe Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 116

FIG. 55 Europe Mobile Cardiac Telemetry Devices Market by End-User, 2018- 2025 (USD Million) 116

FIG. 56 Europe Mobile Cardiac Telemetry Devices Market by Country, 2018- 2025 (USD Million) 117

FIG. 57 Proportional mortality in France by Disease Type (%) 118

FIG. 58 France Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 118

FIG. 59 France Mobile Cardiac Telemetry Devices Market by End-User, 2018- 2025 (USD Million) 119

FIG. 60 Ordinary Telephone Support & TLM Associated with Benefits in terms of Re-Hospitalization & Mortality 121

FIG. 61 Germany Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 122

FIG. 62 Germany Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 122

FIG. 63 THE RITH:M WAY 124

FIG. 64 Sweden Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 125

FIG. 65 Sweden Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 126

FIG. 66 Netherlands Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 128

FIG. 67 Netherlands Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 129

FIG. 68 Causes of Death in Italy by Gender, (%) 2014 130

FIG. 69 Italy Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 134

FIG. 70 Italy Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 134

FIG. 71 United Kingdom Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 136

FIG. 72 United Kingdom Mobile Cardiac Telemetry Devices Market by End-User, 2018- 2025 (USD Million) 136

FIG. 73 Rest of Europe Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 137

FIG. 74 Rest of Europe Mobile Cardiac Telemetry Devices Market by End-User, 2018- 2025 (USD Million) 138

FIG. 75 Asia Pacific Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 139

FIG. 76 Asia Pacific Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 140

FIG. 77 Asia Pacific Mobile Cardiac Telemetry Devices Market by Country, 2018-2025 (USD Million) 140

FIG. 78 Death rate of heart diseases among Japanese males from 2007 to 2016 (per 100,000 population) 141

FIG. 79 Japan Mobile Cardiac Telemetry Devices Market by Technology, 2018-2025 (USD Million) 142

FIG. 80 Japan Mobile Cardiac Telemetry Devices Market by End-User , 2018-2025 (USD Million) 143

FIG. 82 China Mobile Cardiac Telemetry Devices Market by Technology, 2018-2025 (USD Million) 145

FIG. 83 China Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 145

FIG. 85 India Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 147

FIG. 86 India Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 148

FIG. 87 Rest of Asia Pacific Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 149

FIG. 88 Rest of Asia Pacific Mobile Cardiac Telemetry Devices Market by End-User, 2018- 2025 (USD Million) 149

FIG. 89 Rest of World Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 151

FIG. 90 Rest of World Mobile Cardiac Telemetry Devices Market by End-User , 2018-2025 (USD Million) 151

FIG. 91 Rest of World Mobile Cardiac Telemetry Devices Market by Country, 2018-2025 (USD Million) 152

FIG. 92 South Africa Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 154

FIG. 93 South Africa Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 154

FIG. 94 Brazil Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 156

FIG. 95 Brazil Mobile Cardiac Telemetry Devices Market by End-User, 2018-2025 (USD Million) 157

FIG. 96 Other Countries Mobile Cardiac Telemetry Devices Market by Technology, 2018-25 (USD Million) 157

FIG. 97 Other Countries Mobile Cardiac Telemetry Devices Market by End User, 2018-2025 (USD Million) 158

FIG. 98 Porter s Five forces analysis of the Global Mobile Cardiac Telemetry Devices Market 159

FIG. 99 Market Share of Key Players in Precision Agriculture, 2018 (%) 162

FIG. 100 Basic Concept of Cs for Tomorrow 2018 Medium-Term Management Initiative, 2018 167

FIG. 101 Strengths of Asahi Kasei Corporation, 2018 167

FIG. 102 Asahi Kasei Corporation, SWOT Analysis 168

FIG. 103 Key Financials of Asahi Kasei Corporation 169

FIG. 104 Asahi Kasei Corporation, Revenue Split, 2018 (%) 170

FIG. 105 Key Features of BioTelemetry Inc. 173

FIG. 106 BioTelemetry Inc., SWOT Analysis 174

FIG. 107 Key Financials of BioTelemetry Inc. 175

FIG. 108 BioTelemetry Inc., Revenue Split, 2018 (%) 176

FIG. 109 Biotricity, Future Health Applications 179

FIG. 110 Bioflux- single-unit mobile cardiac telemetry (MCT) device 180

FIG. 111 Biolife-a personal heart monitor 180

FIG. 112 Biotricity, SWOT Analysis 182

FIG. 113 Key Financials of Biotricity 182

FIG. 114 Comarch, SWOT Analysis 188

FIG. 115 Key Financials of Comarch 189

FIG. 116 Comarch, Revenue Split, 2018 (%) 190

FIG. 117 Hill-Rom Holdings Inc., Key Facts 194

FIG. 118 Hill-Rom Holdings Inc., Commitment 196

FIG. 119 Hill-Rom Holdings Inc., SWOT Analysis 196

FIG. 120 Key Financials of Hill-Rom Holdings Inc 197

FIG. 121 Hill-Rom Holdings Inc, Revenue Split, 2018 (%) 198

FIG. 122 Traditional Practice Workflow 202

FIG. 123 Practice Workflow with MoMe Kardia 203

FIG. 124 Infobionic, SWOT Analysis 203

FIG. 125 Drivers Designed by Philips to Help Deliver Higher Levels of Customer Value and Quality, Boost Growth, Deliver Winning Solutions, And Improve Results 208

FIG. 126 Koninklijke Philips SWOT Analysis 208

FIG. 127 Key Financials of Koninklijke Philips N.V. 209

FIG. 128 Koninklijke Philips N.V, Revenue Split, 2018 210

FIG. 129 Key Facts of Medicalgorithmics 213

FIG. 130 Medicalgorithmics, SWOT Analysis 215

FIG. 131 Key Financials of Medicalgorithmics 216

FIG. 132 Medicalgorithmics, Revenue Split, 2018 (%) 217

FIG. 133 Medicomp, SWOT Analysis 221

FIG. 134 Cloud Based Preventice Care Platform Servers 224

FIG. 135 Preventice Solutions, Company Credentials 225

FIG. 136 Preventice Solutions, SWOT Analysis 225


List of Table

TABLE 1 Patients' Digital Health Adoption CVD Prevalence 34

TABLE 2 Patients' Digital Health Adoption for Measuring Fitness and Health Improvement (2015) 34

TABLE 3 Number and distribution of persons aged 60 years or over by region, in 2017 and 2050 36

TABLE 4 Top 10 Destinations for Medical Tourism 38

TABLE 5 Summary of Security Threats and Risks in PHDs 43

TABLE 6 Strengths and Efficacies of Different Transitional Care Models and Interventions 46

TABLE 7 Characteristics of ambulatory cardiac monitoring devices 49

TABLE 8 Estimated diagnostic yield of different AECG recording modalities 51

TABLE 9 Advantages and Major Limitations of AECG Techniques 52

TABLE 10 2014 CPT codes for AECG monitoring, Medicare fee schedule, and approved indications 54

TABLE 11 Reimbursement models in Europe 56

TABLE 12 Physician notification criteria for ambulatory cardiovascular telemetry 58

TABLE 13 Reimbursement of cardiologic activities from the NHS 59

TABLE 14 Policy Coverage Criteria 60

TABLE 15 Ambulatory Cardiac Rhythm Monitoring Devices 60

TABLE 16 Applicable Codes 62

TABLE 17 Codes for implantable cardiac monitoring devices (requires precertification) 63

TABLE 18 Codes that do not meet payment determination criteria: 63

TABLE 19 Select Recommendations for Ambulatory ECG and External Monitoring or Telemetry 64

TABLE 20 Provider awareness of telemetry use 68

TABLE 21 Top Product Launches under Mobile Cardiac Telemetry Devices 71

TABLE 22 Top Partnerships under Mobile Cardiac Telemetry Devices 73

TABLE 23 Top Mergers & Acquisitions under Mobile Cardiac Telemetry Devices 74

TABLE 24 Top Business Expansion & Investment under Mobile Cardiac Telemetry Devices 76

TABLE 25 Indications for telemetry include, in consultation with the cardiology team, but not limited to 81

TABLE 26 Commercially Available Lead Based Mobile Telemetry Monitoring Systems 83

TABLE 27 A comprehensive overview of Existing Mobile Cardiac Monitoring devices 87

TABLE 28 Valuation of the B2C telemonitoring venture in the fifth year (in million US dollars)-Netherlands 127

TABLE 29 The Italian experience in TM programs 131

TABLE 30 mHealth benefits in 2017-Brazil 155

TABLE 31 Number of people with the four heart conditions in Brazil, 2015 156

TABLE 32 Asahi Kasei Corporation Key Facts 164

TABLE 33 The product segmentation of Asahi Kasei Corporation 165

TABLE 34 Asahi Kasei Corporation Growth Strategy 166

TABLE 35 Asahi Kasei Corporation Product Launches 170

TABLE 36 Asahi Kasei Corporation Partnerships 171

TABLE 37 Asahi Kasei Corporation Mergers and Acquisitions 171

TABLE 38 BioTelemetry Inc. Key Facts 172

TABLE 39 The product segmentation of BioTelemetry Inc. 173

TABLE 40 BioTelemetry Inc. Growth Strategy 173

TABLE 41 BioTelemetry Inc. Partnerships (Strategic Alliance) 176

TABLE 42 BioTelemetry Inc. Merger and Acquisitions 176

TABLE 43 Biotricity Key Facts 178

TABLE 44 The product segmentation of Biotricity 179

TABLE 45 Biotricity Growth Strategy 181

TABLE 46 Biotricity Product Launch 183

TABLE 47 Biotricity Business Expansion and Investments 184

TABLE 48 Comarch Key Facts 185

TABLE 49 Product segmentation of Comarch 186

TABLE 50 Comarch Growth Strategy 187

TABLE 51 Comarch Partnership 190

TABLE 52 Comarch Business Expansion & Investments 191

TABLE 53 Hill-Rom Holdings Inc, Inc Key Facts 192

TABLE 54 The product segmentation of Hill-Rom Holdings Inc 193

TABLE 55 Hill-Rom Holdings Inc Growth Strategy 194

TABLE 56 Hill-Rom Holdings Inc Product Launches 198

TABLE 57 Hill-Rom Holdings Inc Partnership 199

TABLE 58 Hill-Rom Holdings Inc Expansions and Investments 199

TABLE 59 Hill-Rom Holdings Inc Mergers and Acquisitions 199

TABLE 60 Hill-Rom Holdings Inc Product Launches 200

TABLE 61 Infobionic Key Facts 201

TABLE 62 The product segmentation of InfoBionic 201

TABLE 63 Infobionic Growth Strategy 202

TABLE 64 Infobionic Product Launch 204

TABLE 65 Infobionic Business Expansion and Investment 204

TABLE 66 Koninklijke Philips N.V. Key Facts 205

TABLE 67 The product segmentation of Koninklijke Philips N.V. 206

TABLE 68 Koninklijke Philips N.V. Growth Strategy 207

TABLE 69 Koninklijke Philips N.V. Product Launches 210

TABLE 70 Koninklijke Philips N.V. Partnership 211

TABLE 71 Koninklijke Philips N.V. Merger and Acquisition 211

TABLE 72 Medicalgorithmics Key Facts 212

TABLE 73 The product segmentation of Medicalgorithmics 213

TABLE 74 Medicalgorithmics Growth Strategy 214

TABLE 75 Medicalgorithmics Product Launch 217

TABLE 76 Medicalgorithmics Partnerships 218

TABLE 77 Medicalgorithmics Business Expansions and Investments 218

TABLE 78 Medicalgorithmics Merger & Acquisitions 218

TABLE 79 Medicomp Key Facts 219

TABLE 80 The product segmentation of Medicomp 219

TABLE 81 Medicomp Growth Strategy 220

TABLE 82 Medicomp Corp Product Launches 221

TABLE 83 Preventice Solutions Key Facts 222

TABLE 84 The product segmentation of Preventice Solutions 223

TABLE 85 Preventice Solutions Growth Strategy 224

TABLE 86 Preventice Solutions Product Launches 226

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022